MannKind Corporation Posts In-Line Q4; Expense Falls 35%

By: via Benzinga
MannKind Corp. (NASDAQ: MNKD) gained in Tuesday's extended session after the drug company posted a fourth-quarter loss in line ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.